Le Lézard
Classified in: Health

CMI Media Group Wins Top 10 US Pharmaceutical Company Account


KING OF PRUSSIA, Pa., Feb. 24, 2021 /PRNewswire-PRWeb/ -- CMI Media Group, the leading media strategy, planning, innovation and buying agency for the nation's top healthcare companies and part of WPP (NYSE: WPP), announced it has been chosen by a top 10 pharmaceutical company to provide programmatic and social strategy, as well as HCP media planning and buying.

"This is a big win with an innovative client and we're excited about this partnership," said Justin Freid, Chief Growth & Innovation Officer, CMI Media Group. "We've been seeing more clients interested in expanding the breadth of their media strategy to include programmatic and social, and this trend has led to better results for our clients. Our expert team paired with our proprietary technology made us the clear choice."

Empowertm, the company's integrated planning platform, was a major asset leading to the win. Empower showcases how to deeply understand and directly target audiences on a one to one basis. PROACTtm (Personalized & Responsive Omni-Channel Automated Customer Targeted) is the first and only healthcare media orchestration and automation platform, to get from data to insights to actions immediately. This win is part of a winning streak that has led the company to remarkable YOY growth.

CMI Media Group has brought many firsts to healthcare marketing as the leading healthcare-focused media buying and planning resource to the world's game changers in pharma and life sciences. Those looking to join the CMI Media Group family and embrace the "one dream, one team" culture can visit the company's career page for more information and a link to apply: https://www.cmimediagroup.com/careers

About CMI Media Group
CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group's core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has eight office locations across the US. To apply for a position within our teams, visit https://www.cmimediagroup.com/careers

###

Media Contact

Carly Kuper, CMI Media Group, 6107315409, [email protected]

 

SOURCE CMI Media Group


These press releases may also interest you

at 21:27
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas' XTANDItm (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc....

at 19:15
New Study in Colorado Reveals Alarming Rates of Colorado Teens Missing School
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent to Attend Planet MicroCap Showcase
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

More news about Health...


News published on and distributed by: